Last reviewed · How we verify

Prospective Study of Lead-associated Tricuspid Regurgitation in Patients Undergoing New Transvalvular Lead Insertion (LITR)

NCT07342036 RECRUITING

The goal of this clinical trial is to record the incidence of newly developed or worsening tricuspid valve regurgitation (TR) following the implantation of a pacemaker or defibrillator with a transvenous lead. To collect this data, a transthoracic echocardiogram (TTE) with 3D imaging of the tricuspid valve (TV) will be performed before and after pacemaker implantation, with particular emphasis on assessing the tricuspid valve. Additionally, routine follow-up visits will be conducted at 6 and 12 months post-intervention, during which a TTE, ECG, NT-proBNP measurement, and pacemaker check will be performed.

Details

Lead sponsorHazem Omran
StatusRECRUITING
Enrolment200
Start dateFri Jul 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
CompletionSat Jan 30 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Countries

Germany